Compare J B Hunt Transport Services Inc (JBHT) vs Kymera Therapeutics Inc. Common Stock (KYMR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
J B Hunt Transport Services Inc vs Kymera Therapeutics Inc. Common Stock — how do they compare? J B Hunt Transport Services Inc trades at $221.73 (market cap $21.80B), while Kymera Therapeutics Inc. Common Stock trades at $106.81 (market cap $8.88B). The key difference: J B Hunt Transport Services Inc is far larger — about 2.5× Kymera Therapeutics Inc. Common Stock's market cap, and J B Hunt Transport Services Inc pays a 0.78% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold J B Hunt Transport Services Inc for 46 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| JBHT | KYMR | |
|---|---|---|
Market Cap | $21.80B | $8.88B |
Volume | 1,280,526 | 1,028,790 |
Sector | Industrials | Health |
52-Week High | $298.41 | $127.31 |
52-Week Low | $138.83 | $55.80 |
Typical Hold Time | 46 Days | 0 Days |
Enterprise Value | $22.95B | $8.27B |
Dividend Yield | 0.78% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
JBHT trades at $229.04, up 0.32% with bearish technical signals but strong fundamentals. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 results pending. Revenue has stabilized around $12B with improving net margins from 4.98% in 2025 to projected 5.31% in 2026. Analyst consensus remains bullish with a $287.93 price target, though legal investigations and cost pressures create near-term uncertainty.
The outlook balances strong operational performance against legal and cost headwinds. Investment opportunity lies in continued earnings execution and sector recovery, while risks include ongoing securities investigations and rising fuel/driver expenses that could pressure margins. The stock offers 26% upside to consensus targets if operational momentum continues.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →
